Romidepsin Patent Expiration
Romidepsin was first introduced by Bristol-Myers Squibb Co
Romidepsin Patents
Given below is the list of patents protecting Romidepsin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Istodax | US7608280 | Method of producing FR901228 |
Aug 22, 2021
(Expired) | Bristol-myers |
| Istodax | US7611724 | Method of producing FR901228 |
Aug 22, 2021
(Expired) | Bristol-myers |
| Istodax | US4977138 | FR901228 substance and preparation thereof |
Aug 22, 2013
(Expired) | Bristol-myers |
Romidepsin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List